-
1
-
-
0013920228
-
Cryoglobulinemia-a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability
-
Meltzer M, Franklin EC,. Cryoglobulinemia-a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med 1966; 40: 828-36.
-
(1966)
Am J Med
, vol.40
, pp. 828-836
-
-
Meltzer, M.1
Franklin, E.C.2
-
2
-
-
0016262898
-
Biologic and clinical significance of cryoglobulins: A report of 86 cases
-
Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M,. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775-88.
-
(1974)
Am J Med
, vol.57
, pp. 775-788
-
-
Brouet, J.C.1
Clauvel, J.P.2
Danon, F.3
Klein, M.4
Seligmann, M.5
-
3
-
-
0024509701
-
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral genome
-
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M,. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral genome. Science 1989; 244: 359-62.
-
(1989)
Science
, vol.244
, pp. 359-362
-
-
Choo, Q.L.1
Kuo, G.2
Weiner, A.J.3
Overby, L.R.4
Bradley, D.W.5
Houghton, M.6
-
4
-
-
0026329305
-
Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia
-
Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991; 34: 1606-10.
-
(1991)
Arthritis Rheum
, vol.34
, pp. 1606-1610
-
-
Ferri, C.1
Greco, F.2
Longombardo, G.3
Palla, P.4
Moretti, A.5
Marzo, E.6
-
5
-
-
12044257541
-
Interferon-α in mixed cryoglobulinemic patients: A randomized, crossover, controlled trial
-
Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita L, Vanacore R, et al. Interferon-α in mixed cryoglobulinemic patients: a randomized, crossover, controlled trial. Blood 1993; 81: 1132-6.
-
(1993)
Blood
, vol.81
, pp. 1132-1136
-
-
Ferri, C.1
Marzo, E.2
Longombardo, G.3
Lombardini, F.4
La Civita, L.5
Vanacore, R.6
-
6
-
-
0027997788
-
Natural interferon-α versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: A long-term, randomized, controlled study
-
Dammacco F, Sansonno D, Han JH, Shyamala V, Cornacchiulo V, Iacobelli AR, et al. Natural interferon-α versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 1994; 84: 3336-43.
-
(1994)
Blood
, vol.84
, pp. 3336-3343
-
-
Dammacco, F.1
Sansonno, D.2
Han, J.H.3
Shyamala, V.4
Cornacchiulo, V.5
Iacobelli, A.R.6
-
7
-
-
0028313993
-
Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus
-
Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL,. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-6.
-
(1994)
N Engl J Med
, vol.330
, pp. 751-756
-
-
Misiani, R.1
Bellavita, P.2
Fenili, D.3
Vicari, O.4
Marchesi, D.5
Sironi, P.L.6
-
8
-
-
0036899329
-
Interferon-α and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis
-
Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, et al. Interferon-α and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2002; 46: 3317-26.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 3317-3326
-
-
Cacoub, P.1
Lidove, O.2
Maisonobe, T.3
Duhaut, P.4
Thibault, V.5
Ghillani, P.6
-
9
-
-
33750945860
-
Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemic vasculitis: A long-term followup study
-
Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P,. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemic vasculitis: a long-term followup study. Arthritis Rheum 2006; 54: 3696-706.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 3696-3706
-
-
Saadoun, D.1
Resche-Rigon, M.2
Thibault, V.3
Piette, J.C.4
Cacoub, P.5
-
10
-
-
67349186964
-
Critical analysis of rituximab-induced serological changes in connective tissue diseases
-
Cornec D, Avouac J, Youinou P, Saraux A,. Critical analysis of rituximab-induced serological changes in connective tissue diseases. Autoimmunity Rev 2009; 8: 515-9.
-
(2009)
Autoimmunity Rev
, vol.8
, pp. 515-519
-
-
Cornec, D.1
Avouac, J.2
Youinou, P.3
Saraux, A.4
-
11
-
-
84857738847
-
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
-
De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 2012; 64: 847-54.
-
(2012)
Arthritis Rheum
, vol.64
, pp. 847-854
-
-
De Vita, S.1
Quartuccio, L.2
Isola, M.3
Mazzaro, C.4
Scaini, P.5
Lenzi, M.6
-
12
-
-
84857705804
-
A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis
-
Sneller MC, Hu Z, Langford CA,. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. Arthritis Rheum 2012; 64: 835-46.
-
(2012)
Arthritis Rheum
, vol.64
, pp. 835-846
-
-
Sneller, M.C.1
Hu, Z.2
Langford, C.A.3
-
13
-
-
0028150660
-
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis
-
Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994; 87: 671-8.
-
(1994)
Q J Med
, vol.87
, pp. 671-678
-
-
Luqmani, R.A.1
Bacon, P.A.2
Moots, R.J.3
Janssen, B.A.4
Pall, A.5
Emery, P.6
-
14
-
-
39749085148
-
Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response
-
Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, et al. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum 2008; 58: 604-11.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 604-611
-
-
Landau, D.A.1
Saadoun, D.2
Halfon, P.3
Martinot-Peignoux, M.4
Marcellin, P.5
Fois, E.6
-
15
-
-
77954869956
-
Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: A long-term study
-
Dammacco F, Tucci FA, Lauletta G, Gatti P, De Re V, Conteduca V, et al. Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood 2010; 116: 343-53.
-
(2010)
Blood
, vol.116
, pp. 343-353
-
-
Dammacco, F.1
Tucci, F.A.2
Lauletta, G.3
Gatti, P.4
De Re, V.5
Conteduca, V.6
-
16
-
-
68049110509
-
Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: A long-term followup study of thirty-two patients
-
Terrier B, Saadoun D, Sene D, Sallam J, Perard L, Coppere B, et al. Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients. Arthritis Rheum 2009; 60: 2531-40.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 2531-2540
-
-
Terrier, B.1
Saadoun, D.2
Sene, D.3
Sallam, J.4
Perard, L.5
Coppere, B.6
-
17
-
-
77955915180
-
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease
-
Petrarca A, Rigacci L, Caini P, Colagrande S, Romagnoli P, Vizutti F, et al. Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease. Blood 2010; 116: 335-42.
-
(2010)
Blood
, vol.116
, pp. 335-342
-
-
Petrarca, A.1
Rigacci, L.2
Caini, P.3
Colagrande, S.4
Romagnoli, P.5
Vizutti, F.6
-
18
-
-
80855123812
-
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: Results of multicenter cohort study and review of the literature
-
Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmunity Rev 2011; 11: 48-55.
-
(2011)
Autoimmunity Rev
, vol.11
, pp. 48-55
-
-
Ferri, C.1
Cacoub, P.2
Mazzaro, C.3
Roccatello, D.4
Scaini, P.5
Sebastiani, M.6
-
19
-
-
73249120052
-
Rituximab may form a complex with IgMκ mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis
-
Sene D, Ghillani-Dalbin P, Amoura Z, Musset L, Cacoub P,. Rituximab may form a complex with IgMκ mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. Arthritis Rheum 2009; 60: 3848-55.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 3848-3855
-
-
Sene, D.1
Ghillani-Dalbin, P.2
Amoura, Z.3
Musset, L.4
Cacoub, P.5
-
20
-
-
78649736632
-
Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinemic vasculitis
-
Geri G, Terrier B, Semoun O, Saadoun D, Sene D, Charlotte F, et al. Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinemic vasculitis. Ann Rheum Dis 2010; 69: 2177-80.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 2177-2180
-
-
Geri, G.1
Terrier, B.2
Semoun, O.3
Saadoun, D.4
Sene, D.5
Charlotte, F.6
-
21
-
-
0037063113
-
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection
-
Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89-94.
-
(2002)
N Engl J Med
, vol.347
, pp. 89-94
-
-
Hermine, O.1
Lefrere, F.2
Bronowicki, J.P.3
Mariette, X.4
Jondeau, K.5
Eclache-Saudreau, V.6
-
22
-
-
19944429608
-
Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: A new entity?
-
Saadoun D, Suarez F, Lefrere F, Valensi F, Mariette X, Aouba A, et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005; 105: 74-6.
-
(2005)
Blood
, vol.105
, pp. 74-76
-
-
Saadoun, D.1
Suarez, F.2
Lefrere, F.3
Valensi, F.4
Mariette, X.5
Aouba, A.6
-
23
-
-
1642554816
-
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection
-
Sansonno D, Lauletta G, De Re V, Tucci FA, Gatti P, Racanelli V, et al. Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection. Eur J Immunol 2004; 34: 126-36.
-
(2004)
Eur J Immunol
, vol.34
, pp. 126-136
-
-
Sansonno, D.1
Lauletta, G.2
De Re, V.3
Tucci, F.A.4
Gatti, P.5
Racanelli, V.6
-
25
-
-
77954230618
-
Detection of WA B cells in hepatitis C virus infection: A potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies
-
Knight GB, Gao L, Gragnani L, Elfahal MM, De Rosa FG, Gordon FD, et al. Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies. Arthritis Rheum 2010; 62: 2152-9.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 2152-2159
-
-
Knight, G.B.1
Gao, L.2
Gragnani, L.3
Elfahal, M.M.4
De Rosa, F.G.5
Gordon, F.D.6
-
26
-
-
79955374432
-
Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement
-
Chen Z, Zhu Y, Ren Y, Tong Y, Hua X, Zhu F, et al. Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement. PLos One 2011; 6: e18933.
-
(2011)
PLos One
, vol.6
-
-
Chen, Z.1
Zhu, Y.2
Ren, Y.3
Tong, Y.4
Hua, X.5
Zhu, F.6
-
27
-
-
0036787033
-
Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas
-
Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002; 137: 571-80.
-
(2002)
Ann Intern Med
, vol.137
, pp. 571-580
-
-
Zignego, A.L.1
Ferri, C.2
Giannelli, F.3
Giannini, C.4
Caini, P.5
Monti, M.6
-
28
-
-
1842479859
-
Diagnosis, management, and treatment of hepatitis C
-
Strader DB, Wright T, Thomas DL, Seef LB,. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39: 1147-71.
-
(2004)
Hepatology
, vol.39
, pp. 1147-1171
-
-
Strader, D.B.1
Wright, T.2
Thomas, D.L.3
Seef, L.B.4
-
29
-
-
77955857269
-
Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C-related mixed cryoglobulinemia
-
Saadoun D, Rigon MR, Sene D, Terrier B, Karras A, Perard L, et al. Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood 2010; 116: 326-34.
-
(2010)
Blood
, vol.116
, pp. 326-334
-
-
Saadoun, D.1
Rigon, M.R.2
Sene, D.3
Terrier, B.4
Karras, A.5
Perard, L.6
-
30
-
-
80053339008
-
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
-
Ghany MG, Nelson DR, Strader DB, Thomas DL, Seef LB,. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54: 1433-44.
-
(2011)
Hepatology
, vol.54
, pp. 1433-1444
-
-
Ghany, M.G.1
Nelson, D.R.2
Strader, D.B.3
Thomas, D.L.4
Seef, L.B.5
|